AU
UK
CA
NZ
IND
US
Image source: © 2025 Krish Capital Pty.LtdHighlightsTruBridge posted Q2 2025 GAAP net income of USD 2.6 million versus a USD 4.4 million loss last year.Total revenue was USD 85.7 million, with recurring revenue comprising 95% of the total.Adjusted EBITDA rose to USD 13.7 million …
Baxter International Inc. (NYSE: BAX) has seen a wave of analyst activity following a series of price target revisions. Barclays recently cut its price target for the medical instruments supplier from USD 41.00 to USD 36.00, while maintaining an “overweight” rating on the stock. …
Mdxhealth (NASDAQ: MDXH) has reported its preliminary financial results for the second quarter and first half of fiscal year 2025, along with a strategic acquisition intended to accelerate its growth trajectory. For the quarter ended June 30, 2025, the company posted a 20% year-over-year …
Alcon (SIX/NYSE: ALC) and STAAR Surgical Company (NASDAQ: STAA) announced a definitive merger agreement under which Alcon will acquire STAAR in a transaction valued at approximately $1.5 billion. The deal, which includes the EVO Implantable Collamer® Lens (EVO ICL™) family, aims to expand Alcon’s …
Zepp Health Corporation (NYSE: ZEPP) announced unaudited financial results for the second quarter of 2025, marking its first year-over-year revenue growth since 2021. Total revenue came in at USD 59.4 million, representing a 46.2% increase over the same period in 2024 and a 54.2% …
Indivior (NASDAQ:INDV) has earned a consensus rating of "Buy" from the five brokerages that are presently covering the stock, according to Reuters. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. …
ImageneBio, Inc. (Nasdaq: IMA) will commence trading on the Nasdaq Capital Market at market open on July 28, 2025, following the completed merger between Inmagene Biopharmaceuticals and Ikena Oncology, Inc. The combined clinical-stage biotechnology company will continue its focus on immunological and inflammatory diseases, …
Jefferies has upgraded Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) fromHoldtoBuywhile marginally lowering its price target to USD6 from USD6.25, according to a recent note issued ahead of the company’s upcoming second-quarter earnings report. Despite a modest downward adjustment in valuation, the firm’s updated stance …
AstraZeneca PLC (NASDAQ: AZN) has received a consensus recommendation of “Moderate Buy” from the six analysts currently covering the stock, according to a recent report byMarketBeat.com. Among them, one issued a "Hold" rating while five analysts rated the stock a "Buy". The average 12-month …
COMPASS Pathways plc (NASDAQ: CMPS), a clinical-stage mental health care company, received renewed attention from analysts this week after HC Wainwright reaffirmed its “Buy” rating on the stock. The firm maintained its ambitious price target of USD 45.00, based on expectations surrounding the development …
Please wait processing your request...